NEOGENOMICS INC — Director's Dealing 2022

Dec 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-12-01

Reporting Person: Stone Warren (President, Clinical Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-01	Common Stock	A	89206	—	Acquired	89206	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-01	Stock Option (Right to Buy)	$11.21	A	166113	Acquired	2029-12-01	Common Stock (166113.0)	Direct

Footnotes

F1: On December 1, 2022, Mr. Stone was granted 89,206 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.